Zymeworks (ZYME) Prices 12.5M Share and Warrant Offering at $8/sh

Go back to Zymeworks (ZYME) Prices 12.5M Share and Warrant Offering at $8/sh

Zymeworks Announces Pricing of $100.0 Million Public Offering

January 26, 2022 9:36 PM EST

VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the pricing of its underwritten public offering of 9,160,000 common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 3,340,000 common shares. The common shares are being offered at a public offering price of $8.00 per common share and the pre-funded warrants are being offered at a public offering price of $7.9999 per pre-funded warrant, which represents the per share public offering price for each common share less the $0.0001 per share... More